These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1290689)

  • 1. Hypoxia as a determinant factor in radiotherapy? Where are we?
    Guichard M
    BJR Suppl; 1992; 24():142-5. PubMed ID: 1290689
    [No Abstract]   [Full Text] [Related]  

  • 2. The potential for improving radiotherapy outcome by improving the oxygen supply to solid tumours.
    Denekamp J; Waites A
    Strahlenther Onkol; 1996 Nov; 172 Suppl 2():22-3. PubMed ID: 8946041
    [No Abstract]   [Full Text] [Related]  

  • 3. Oxygen diffusion and the distribution of cellular radiosensitivity in tumours.
    Tannock IF
    Br J Radiol; 1972 Jul; 45(535):515-24. PubMed ID: 5067983
    [No Abstract]   [Full Text] [Related]  

  • 4. [Radiosensitizers of hypoxic cells].
    Girinsky T; Cosset JM; Malaise EP; Guichard M
    Rev Prat; 1989 Nov; 39(27):2440. PubMed ID: 2602869
    [No Abstract]   [Full Text] [Related]  

  • 5. Letter: Comparison of tumour growth delay with cell survival.
    Brown JM; Howes AE
    Br J Radiol; 1974 Aug; 47(560):509-10. PubMed ID: 4419872
    [No Abstract]   [Full Text] [Related]  

  • 6. The influence of the oxygen:nitrogen sensitivity ratio on theoretical dose:cure-rate relations.
    Munro TR
    Br J Radiol; 1967 Aug; 40(476):619-26. PubMed ID: 4952298
    [No Abstract]   [Full Text] [Related]  

  • 7. Letter: Tumour growth delay and cell survival "in situ".
    McNally NJ
    Br J Radiol; 1974 Aug; 47(560):510-1. PubMed ID: 4420115
    [No Abstract]   [Full Text] [Related]  

  • 8. Hypoxia and radiotherapy: opportunities for improved outcomes in cancer treatment.
    Moeller BJ; Richardson RA; Dewhirst MW
    Cancer Metastasis Rev; 2007 Jun; 26(2):241-8. PubMed ID: 17440683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Radiobiologic factors modifying the effect of irradiation on tumor cell populations (author's transl)].
    Siracká E
    Bratisl Lek Listy; 1981 Apr; 75(4):393-9. PubMed ID: 7272806
    [No Abstract]   [Full Text] [Related]  

  • 10. TCP modelling - why is it important?
    Carlone M; Nahum A; Stavrev P
    Acta Oncol; 2010 Nov; 49(8):1205. PubMed ID: 20950225
    [No Abstract]   [Full Text] [Related]  

  • 11. HIF-1 and tumour radiosensitivity.
    Moeller BJ; Dewhirst MW
    Br J Cancer; 2006 Jul; 95(1):1-5. PubMed ID: 16735998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ARCON: accelerated radiotherapy with carbogen and nicotinamide.
    Rojas A
    BJR Suppl; 1992; 24():174-8. PubMed ID: 1290695
    [No Abstract]   [Full Text] [Related]  

  • 13. Optimization of tumor radiotherapy with modulators of cell metabolism: toward clinical applications.
    Danhier P; De Saedeleer CJ; Karroum O; De Preter G; Porporato PE; Jordan BF; Gallez B; Sonveaux P
    Semin Radiat Oncol; 2013 Oct; 23(4):262-72. PubMed ID: 24012340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiobiological data on time-dose relationships.
    Fowler JF
    Radiol Clin Biol; 1973; 42(1):1-15. PubMed ID: 4574016
    [No Abstract]   [Full Text] [Related]  

  • 15. ARCON.
    Rojas A
    Strahlenther Onkol; 1996 Nov; 172 Suppl 2():34-5. PubMed ID: 8946047
    [No Abstract]   [Full Text] [Related]  

  • 16. The effects of hypoxia on the theoretical modelling of tumour control probability.
    Daşu A; Toma-Daşu I; Karlsson M
    Acta Oncol; 2005; 44(6):563-71. PubMed ID: 16165915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative aspects of normal tissue damage tolerance for megavoltage irradiation in hyperbaric oxygen.
    Van Den Brenk HA
    Nunt Radiol; 1968 Jan; 34(1):69-78. PubMed ID: 5717163
    [No Abstract]   [Full Text] [Related]  

  • 18. Time-dose relationships in radiotherapy.
    Fowler JF; Thomlinson RH; Howes AE
    Eur J Cancer (1965); 1970 Jun; 6(3):207-21. PubMed ID: 4920612
    [No Abstract]   [Full Text] [Related]  

  • 19. [The significance of tumor size in radiotherapy using modifiers].
    Kozin SV; Furmanchuk AV
    Med Radiol (Mosk); 1990 May; 35(5):49-55. PubMed ID: 2188055
    [No Abstract]   [Full Text] [Related]  

  • 20. Consideration of fractionation schedules for radiation dose.
    Suit HD
    Radiology; 1972 Oct; 105(1):151-6. PubMed ID: 5057296
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.